Leigh Disease With Mitochondrial DNA A8344G Mutation: Case Report and Brief Review

Abstract

Leigh disease, subacute necrotizing encephalomyelopathy, is a neurodegenerative disorder often seen in infancy or childhood but rarely reported in adults. Genetic heterogeneity is well recognized, and the associated etiologies include both mitochondrial and nuclear DNA defects. We describe an infant presenting with developmental delay and then progressive multisystem disorder and neuroradiologic features of Leigh disease. He and his maternal relatives all have the A8344G mitochondrial DNA mutation. However, only minor clinical features are seen in his maternal relatives, with migraine being the most common problem. Additionally, the A8344G mitochondrial DNA mutation is associated with spinocerebellar degeneration, other nonspecific mitochondrial encephalomyopathies, atypical Charcot-Marie-Tooth disease, and progressive external ophthalmoplegia. The A8344G mitochondrial DNA mutation may present with Leigh disease or other different atypical clinical features without myoclonic epilepsy and ragged red fibers. (J Child Neurol 2003; 18: 62—64).

Get full access to this article

View all access options for this article.

References

Shoffner JM , Lott MT , Lezza Ams , et al: Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 1990;61:931—937.

Silvestri G. , Ciafaloni E. , Santorelli FM , et al: Clinical features associated with the A→G transition at nucleotide 8344 of mitochondrial DNA (“MERRF mutation”). Neurology 1993;43:1200—1206.

Berkovic SF , Shoubridge EA , Andermann F. , et al: Clinical spectrum ofmitochondrialDNAmutationatbasepair8344. Lancet 1991;338:457—458.

Howell N. , Kubacka I. , Smith R. , et al: Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease. Neurology 1996;46:219—222.

Santorelli FM , Tanji K. , Shanske S. , et al: The mitochondrial DNA A8344G mutation in Leigh syndrome revealed by analysis in paraffin-embedded sections: Revisiting the past. Ann Neurol 1998;44:962—964.

Moraes CT , Schon EA , DiMauro S. : Mitochondrial diseases: Toward a rational classification, in Appel SH (ed): Current Neurology, vol 11. St. Louis, Mosby Year Book, 1991, 83—119.

Hammans SR , Sweeney MG , Brockingham M. , et al: The mitochondrial DNA transfer RNA Lys A > G (8344) mutation and syndrome of myoclonic epilepsy with ragged red fibers (MERRF). Brain 1993;116:617—632.

Seibel P. , Degoul F. , Bonne G. , et al: Genetic, biochemical and pathophysiological characterization of a familial mitochondrial encephalopathy (MERRF). J Neurol Sci 1991;105:217—224.

Tanno Y. , Yoneda M. , Nonaka I. , et al: Quantitation of mitochondrial DNA carrying tRNA lys mutation in MERRF patients. Biochem Biophys Res Commun 1991;179:880—885.

10.

Baumgartner ER , Sourmala TM , Wick H. , et al: Biotinidase deficiency: A cause of subacute necrotizing encephalomyelopathy (Leigh syndrome). Report of a case with lethal outcome. Pediatr Res 1989;26: 260—266.

11.

DiMauro S. , DeVivo DC : Genetic heterogeneity in Leigh syndrome. Ann Neurol 1996;40:5—7.

12.

Absalon MJ , Harding CO , Fain DR , et al: Leigh syndrome in an infant resulting from mitochondrial DNA depletion. Pediatr Neurol 2001; 24:60—63.

13.

Chinnery PF , Turnbull DM : Mitochondrial DNA and disease. Lancet 1999 ;354:17—21.

14.

Carrozzo R. , Tessa ME , Vazquez-Memije ME , et al: The T9176G mitochondrial DNA mutation severely affects ATP production and results in Leigh syndrome. Neurology 2001 ;56:687—690.

15.

Shtilbans A. , Shanske S. , Goodman S. , et al: G8363A mutation in the mitochondrial DNA transfer ribonucleic acidlys gene: Another cause of Leigh syndrome. J Child Neurol 2000; 15: 759—761.

16.

Tsao CY , Luquette M. , Rusin JA , et al: Leigh syndrome, infantile spasm, cytochrome c oxidase deficiency and hypsarrhythmia with infantile spasms. Clin Electroencephalogr 1997;28:214—217.

17.

Rahman S. , Blok RB , Dahl Hhm , et al: Leigh syndrome: Clinical features and biochemical and DNA abnormalities . Ann Neurol 1996;39: 343—351.

18.

Santorelli FM , Shanske S. , Macaya A. , et al: The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 1993;34:827—834.

19.

De Vries DD , van Engelen Bgm , Gabreels Fjm , et al: A 2nd missense mutation in the mitochondrial ATPase-6 gene in Leigh's syndrome. Ann Neurol 1993; 34: 410—412.

20.

Mak S-C. , Chi C-S. , Liu C-Y. , et al: Leigh syndrome associated with mitochondrial DNA 8993 T → G mutation and ragged-red fibers. Pediatr Neurol 1996; 15: 72—75.

21.

Moraes CT , Ciacci F. , Silvestri G. , et al: Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 1993;3:43—50.

22.

Tsao CY , Mendell JR , Bartholomew D. : High mitochondrial DNA T8993G mutation (>90%) without typical features of Leigh's and NARP syndromes. J Child Neurol 2001;16:533—535.